Progyny, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Progyny, Inc. (PGNY), sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are PGNY insiders buying or selling?
In the last 12 months, Progyny, Inc. insiders reported 1 open-market purchase ($1.9M) and 20 sales ($2.6M) — net selling of $684.2K. Since October 2019, Trabud has recorded 402 Form 4 filings for PGNY: 4 buys ($8.2M) and 398 sells ($1.2B).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $1.9M by Peter Anevski (CHIEF EXECUTIVE OFFICER) on Nov 17, 2025. SEC ↗
- The most recent open-market purchase was reported on Nov 17, 2025 (11 months ago).
Key Statistics (October 2019 – Oct 16, 2026)
Insider sentiment
Net sellingNet insider flow of $1.2B in net selling since October 2019, and $684.2K in net selling over the last 12 months.
Recent PGNY insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Melissa B Cummings | Chief Operating Officer | Sale | 1.9K | $28.00 | $52.6K | SEC ↗ |
| Sep 28, 2026 | Allison Swartz | EVP, GC | Sale | 3.9K | $26.10 | $101.9K | SEC ↗ |
| Sep 18, 2026 | Kevin K Gordon | Director | Sale | 11.5K | $27.12 | $311.9K | SEC ↗ |
| Sep 14, 2026 | Kevin K Gordon | Director | Sale | 11.5K | $27.94 | $321.4K | SEC ↗ |
| Jul 16, 2026 | Melissa B Cummings | Chief Operating Officer | Sale | 2.2K | $31.60 | $70.9K | SEC ↗ |
| Jun 5, 2026 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sale | 2.5K | $25.50 | $64.2K | SEC ↗ |
| Jun 5, 2026 | Allison Swartz | EVP, GC | Sale | 1.8K | $25.04 | $45.0K | SEC ↗ |
| Jun 3, 2026 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sale | 279 | $26.20 | $7.3K | SEC ↗ |
| Jun 3, 2026 | Cheryl Scott | Director | Sale | 7.4K | $26.39 | $196.3K | SEC ↗ |
| Jun 3, 2026 | Geoffrey Clapp | Chief Product Officer | Sale | 1.5K | $25.58 | $39.1K | SEC ↗ |
| Jun 1, 2026 | Allison Swartz | EVP, GC | Sale | 2.4K | $25.46 | $61.1K | SEC ↗ |
| May 29, 2026 | Kevin K Gordon | Director | Sale | 5.5K | $24.99 | $137.4K | SEC ↗ |
| May 21, 2026 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sale | 8.3K | $25.50 | $211.0K | SEC ↗ |
| May 21, 2026 | Melissa B Cummings | Chief Operating Officer | Sale | 9.6K | $25.00 | $239.4K | SEC ↗ |
| Mar 6, 2026 | Allison Swartz | EVP, GC | Sale | 599 | $17.54 | $10.5K | SEC ↗ |
| Mar 4, 2026 | Allison Swartz | EVP, GC | Sale | 6.9K | $17.36 | $119.0K | SEC ↗ |
| Dec 8, 2025 | Allison Swartz | EVP, GC | Sale | 530 | $24.59 | $13.0K | SEC ↗ |
| Dec 4, 2025 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sale | 213 | $25.50 | $5.4K | SEC ↗ |
| Dec 2, 2025 | Allison Swartz | EVP, GC | Sale | 2.4K | $26.87 | $64.4K | SEC ↗ |
| Nov 19, 2025 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sale | 21.3K | $25.50 | $543.2K | SEC ↗ |
| Nov 17, 2025 | Peter Anevski | CHIEF EXECUTIVE OFFICER | Purchase | 79.5K | $24.29 | $1.9M | SEC ↗ |
| Sep 5, 2025 | Allison Swartz | EVP, GC | Sale | 599 | $23.53 | $14.1K | SEC ↗ |
| Sep 2, 2025 | Allison Swartz | EVP, GC | Sale | 2.4K | $22.96 | $55.1K | SEC ↗ |
| Aug 13, 2025 | Kevin K Gordon | Director | Sale | 2.5K | $22.04 | $55.1K | SEC ↗ |
| Jun 12, 2025 | Cheryl Scott | Director | Sale | 2.7K | $22.07 | $59.0K | SEC ↗ |
Showing the 25 most recent of 402 Form 4 filings for Progyny, Inc..
Most active PGNY insiders
- Norman Payson109 filings
- David J Schlanger79 filings
- Peter Anevski70 filings
- David Bonderman57 filings
- Jennifer Bealer18 filings
Ask anything about PGNY insider activity
Use Trabud's AI agent to query Progyny, Inc.'s Form 4 history in plain English — "Show me PGNY CEO purchases this year" or compare it against any other ticker.
Open the AI agentPGNY insider trading FAQ
Are Progyny, Inc. insiders buying or selling?
In the last 12 months, Progyny, Inc. insiders reported 1 open-market purchase ($1.9M) and 20 sales ($2.6M) — net selling of $684.2K. Since October 2019, Trabud has recorded 402 Form 4 filings for PGNY: 4 buys ($8.2M) and 398 sells ($1.2B). Over the full record that is net selling of $1.2B.
How many insiders trade PGNY stock?
18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Progyny, Inc.. The most recent filing was accepted on Oct 16, 2026.
Where does Trabud get PGNY insider trading data?
All PGNY insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.